Answers are grounded in this paper and cite their sources.
Osteoporosis compromises bone repair through reduced osteogenic capacity, excessive osteoclast activity, oxidative stress, inflammation, impaired angiogenesis, and poor implant fixation. Three-dimensional printing has emerged as a powerful strategy to generate patient-specific scaffolds and implants with controlled porosity, mechanical properties, and bioactive interfaces. In osteoporotic bone, however, passive structural support is often insufficient, prompting the development of drug-loaded, immunomodulatory, antioxidant, osteoanabolic, and stimuli-responsive systems. This mini-review summarizes recent evidence on 3D- and 4D-printed scaffolds for osteoporosis, with emphasis on in vivo preclinical studies and human-oriented translational data. Current studies show that 3D-printed titanium, tantalum, magnesium alloy, calcium phosphate, bioactive glass, polycaprolactone (PCL), polylactic acid (PLA), polyetheretherketone (PEEK), and hybrid hydrogel-integrated scaffolds can enhance osseointegration and bone regeneration in osteoporotic animal models. Functional strategies include local delivery of simvastatin, zoledronic acid, alendronate, teriparatide, bone morphogenic proteins, platelet-rich plasma, strontium, magnesium, lanthanum, cerium, icaritin, and antioxidant or immunomodulatory agents. Emerging 4D-like systems introduce responsiveness to pH, reactive oxygen species (ROS), enzymes, temperature, magnetic fields, microcurrent, or near-infrared irradiation, enabling sequential release, self-healing, photothermal activation, and microenvironment-adaptive repair. Despite strong preclinical progress, true human clinical evidence remains scarce, and most human-oriented work is limited to finite element modeling, patient-specific implant design, biomechanical testing, cadaveric studies, or imaging phantoms. Translation will require large-animal validation, standardized osteoporotic models, long-term safety data, regulatory alignment, and comparative studies against current clinical standards.
No takes yet. Share an insight, caveat, or question.
Castro-Rodríguez et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: